Shanghai Obio Technology (Group) Corp., Ltd. (SHA:688238)

China flag China · Delayed Price · Currency is CNY
6.80
+0.24 (3.66%)
Mar 27, 2026, 4:00 PM EDT
Market Cap4.30B +22.9%
Revenue (ttm)267.66M +7.9%
Net Income-220.72M
EPS-0.35
Shares Out630.31M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,036,840
Average Volume14,007,958
Open6.49
Previous Close6.56
Day's Range6.44 - 6.83
52-Week Range4.49 - 9.20
Beta0.60
RSI44.75
Earnings DateApr 21, 2026

About SHA:688238

Shanghai Obio Technology (Group) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China. The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing process, for basic research, translational research and clinical trials. It also provides CDMO services encompassing process development, analytica... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 678
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688238
Full Company Profile

Financial Performance

In 2025, SHA:688238's revenue was 267.66 million, an increase of 7.86% compared to the previous year's 248.15 million. Losses were -220.72 million, -31.41% less than in 2024.

Financial Statements